Appendix 3Y Change of Director’s Interest Notice
The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 11 November 2021. Please click the review the full announcement at ASX.
The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 11 November 2021. Please click the review the full announcement at ASX.
The document “Application for quotation of +securities” was lodged with ASX on November 11, 2021. Please click to review the full announcement at ASX.
Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 5 November 2021 and 11 November 2021 the Company issued 14,490,291 fully paid ordinary
The document “Response to ASX Price Query” was lodged with ASX on 9 November, 2021. Please click to review the full announcement at ASX.
The document “Application for quotation of +securities” was lodged with ASX on 4 November 2021. Please click to review the full announcement at ASX.
Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 29 October 2021 and 4 November 2021 the Company issued 7,075,649 fully paid ordinary
Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 22 October 2021 and 28 October 2021 the Company issued 5,730,814 fully paid ordinary
Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 15 October 2021 and 21 October 2021 the Company issued 3,904,910 fully paid ordinary
The document “Application for quotation of +securities” was lodged with ASX on 21 October, 2021. Please click to review the full announcement at ASX.
The document “Notice to IBXO Option Holders” was lodged with ASX on 14 October, 2021. Please click to review the full announcement on ASX.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance